Results 211 to 220 of about 1,415,363 (344)
Cox-McFadden Partial and Marginal Likelihoods for the Proportional Hazard Model with Random Effects [PDF]
Jan Ondrich
openalex +1 more source
Rolling Ultrasharp Microneedle Spheres Enable Topical Delivery of Biologics Through the Skin
Rolling ultraminiaturized microneedle spheres (RUMS), created via two‐photon polymerization, unlock effective and painless topical delivery of messenger RNA (mRNA) and drugs through the skin. By gently forming thousands of microscopic pores, RUMS boost skin permeability by up to 100‐fold.
Theocharis Nikiforos Iordanidis+6 more
wiley +1 more source
Restricted mean survival time approach versus time-varying coefficient Cox model for quantifying treatment effect when hazards are non-proportional. [PDF]
Gu T, Chen Z, Soon YY, Wee J, Tai BC.
europepmc +1 more source
Biologically Active Implants Prevent Mortality in a Mouse Sepsis Model
A modular, triple‐action titanium implant is developed to prevent implant‐associated infections by repelling bacteria, killing pathogens, and enhancing tissue integration. Coatings with phage cocktails targeting P. aeruginosa and S. aureus show significant bacterial reduction and improved survival in a mouse sepsis model.
Martin Stark+9 more
wiley +1 more source
Robust variable selection methods with Cox model-a selective practical benchmark study. [PDF]
Zhang Y, Muller S.
europepmc +1 more source
A novel blood‐brain barrier‐penetrating terpolymer nanoparticle to deliver brain‐derived neurotrophic factor (BDNF) for the treatment of Alzheimer's disease (AD) is designed. The BDNF‐TPN significantly enhances BDNF accumulation in the brain following intravenous injection, reduces apoptosis and neuroinflammation, thus promoting neuronal survival and ...
Lily Yi Li+8 more
wiley +1 more source
Bayesian Inferences in the Cox Model for Order‐Restricted Hypotheses
David B. Dunson, Amy H. Herring
openalex +2 more sources
THE COX PROPORTIONAL HAZARDS MODEL WITH A PARTIALLY KNOWN BASELINE [PDF]
Mai Zhou
openalex +1 more source
This study introduces a new lipopolymer nanoparticle (LPNP) system that efficiently delivers siRNA to leukemia cells. The LPNPs silence the leukemia fusion gene KMT2A::AFF1, induce apoptosis, and decrease leukemia burden in mice. These results demonstrate the potential of LPNPs as a targeted siRNA therapy for acute lymphoblastic leukemia.
Mohammad Nasrullah+9 more
wiley +1 more source